References
- Haggar, F.A., Boushey, R.P. (2009). Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin. Colon Rectal Surg. 22(4): 191-197. doi: https://doi.org/10.1055/s-0029-1242458
- Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71(3): 209-249. doi: https://doi.org/10.3322/caac.21660
- Wenzel, U., Kuntz, S., Brendel, M.D., Daniel, H. (2000). Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 60(14): 3823-3831.
- Mármol, I., Sánchez-de-Diego, C., Dieste, A.P., Cerrada, E., Yoldi, M.J.R. (2017). Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int. J. Mol. Sci. 18: 197. doi: https://doi.org/10.3390/ijms18010197
- Huerta, S., Goulet, E.J., Livingston, E.H. (2006). Colon cancer and apoptosis. Am. J. Surg. 191(4): 517-526. doi: https://doi.org/10.1016/j.amjsurg.2005.11.009
- Bates, S., Ryan, K.M., Phillips, A.C., Vousden, K.H. (1998). Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene. 17(13): 1691-1703. doi: https://doi.org/10.1038/sj.onc.1202104
- Rossi, H., Rothenberger, D. (2006). Surgical treatment of colon cancer. Surg. Oncol. Clin. N Am. 15(1):109-127. doi: https://doi.org/10.1016/j.soc.2005.08.005
- Häfner, M., Debus, J. (2016). Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives. Visc. Med. 32(3): 172-177. doi: https://doi.org/10.1159/000446486
- Moertel, C.G. (1994). Chemotherapy for Colorectal Cancer. N. Engl. J. Med. 330(16): 1136-1142. doi: https://doi.org/10.1056/NEJM199404213301608
- Markman, J., Shiao, S. (2015). Impact of the immune system and immunotherapy in colorectal cancer. J. Gastrointest. Oncol. 6(2): 208-223.
- Rejhová, A., Opattová, A., Čumová, A., Slíva, D., Vodička, P. (2018). Natural compounds and combination therapy in colorectal cancer treatment. Eur. J. Med. Chem. 144:582-594. doi: https://doi.org/10.1016/j.ejmech.2017.12.039
- Gullett, N.P., Amin, A.R.M.R., Bayraktar, S., Pezzuto, J.M., Shin, D.M., Khuri, F.R., Aggarwal, B.B., Surh, Y.J., Kucuk, O. (2010). Cancer prevention with natural compounds. Semin. Oncol. 37(3): 258-281. doi: https://doi.org/10.1053/j.seminoncol.2010.06.014
- Cirmi, S., Ferlazzo, N., Lombardo, G.E., Maugeri, A., Calapai, G., Gangemi, S., Navarra, M. (2016). Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives? Nutrients. 8(11): 698. doi: https://doi.org/10.3390/nu8110698
- Dholakiya, S., Benzeroua, L. (2011). Protective effect of diosmin on LPS-induced apoptosis in PC12 cells and inhibition of TNF-α expression. Toxicol. In Vitro. 25(5): 1039-1044. doi: https://doi.org/10.1016/j.tiv.2011.04.003
- Naso, L., Martínez, V.R., Lezama, L., Salado, C., Valcarcel, M., Ferrer, E.G., Williams, P.A.M. (2016). Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin. Bioorg. Med. Chem. 24(18): 4108-4119. doi: https://doi.org/10.1016/j.bmc.2016.06.053
- Vinayagam, R., Xu, B. (2015). Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr. Metab. 12(1): 1-20. doi: https://doi.org/10.1186/s12986-015-0057-7
- Lewinska, A., Adamczyk-Grochala, J., Kwasniewicz, E., Deregowska, A., Wnuk, M. (2017). Diosmin-induced senescence, apoptosis and autophagy in breast cancer cells of different p53 status and ERK activity. Toxicol. Lett. 265: 117-130. doi: https://doi.org/10.1016/j.toxlet.2016.11.018
- Kilit, A.C., Köse, E.O., Imir, N.G., Aydemir, E. (2021). Anticancer and antimicrobial activities of diosmin. Genet. Mol. Res. 20(1): 1-18. doi: https://doi.org/10.4238/gmr18752
- Cincin, Z.B., Unlu, M., Kiran, B., Bireller, E.S., Baran, Y., Cakmakoglu, B. (2015). Apoptotic Effects of Quercitrin on DLD-1 Colon Cancer Cell Line. Pathol. Oncol. Res. 21(2): 333-338. doi: https://doi.org/10.1007/s12253-014-9825-3
- Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65(1-2): 55-63. doi: https://doi.org/10.1016/0022-1759(83)90303-4
- Ramachandran, R., Saraswathy, M. (2014). Up-regulation of nuclear related factor 2 (NRF2) and antioxidant responsive elements by metformin protects hepatocytes against the acetaminophen toxicity. Toxicol Res. 3(5): 350. doi: https://doi.org/10.1039/C4TX00032C
- Zheng, Y., Zhang, R., Shi, W., Li, L., Liu, H., Chen, Z., Wu, L. (2020). Metabolism and pharmacological activities of the natural health-benefiting compound diosmin. Food Funct. 11(10): 8472-8492. doi: https://doi.org/10.1039/D0FO01598A
- Sreevalsan, S., Safe, S. (2013). Reactive oxygen species and colorectal cancer. Curr. Colorectal. Cancer Rep. 9(4): 350. doi: https://doi.org/10.1007/s11888-013-0190-5
- Lin, S., Li, Y., Zamyatnin, A.A., Werner, J., Bazhin, A.V. (2018). Reactive oxygen species and colorectal cancer. J. Cell Physiol. 233(7): 5119-5132. doi: https://doi.org/10.1002/jcp.26356
- Lewinska, A., Siwak, J., Rzeszutek, I., Wnuk, M. (2015). Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line. Toxicol In Vitro. 29(3): 417-425. doi: https://doi.org/10.1016/j.tiv.2014.12.005
- Maximov, G.K., Maximov, K.G. (2014). The Role of p53 Tumor-Suppressor Protein in Apoptosis and Cancerogenesis. Biotechnology & Biotechnological Equipment. 22(2): 664-668. doi: https://doi.org/10.1080/13102818.2008.10817532
- Yin, X., Zhang, R., Feng, C., Zhang, J., Liu, D., Xu, K., Wang, X., Zhang, S., Li, Z., Liu, X., Ma, H. (2014). Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma. Oncol. Rep. 32(4): 1748-1756. doi: https://doi.org/10.3892/or.2014.3361
- Bartke, T., Siegmund, D., Peters, N., Reichwein, M., Henkler, F., Scheurich, P., Wajant, H. (2001). p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene. 20(5): 571-580. doi: https://doi.org/10.1038/sj.onc.1204124
- Kawada, M., Usami, I., Ohba, S., Someno, T., Kim, J.W., Hayakawa, Y., Nose, K., Ishizuka, M. (2002). Hygrolidin induces p21 expression and abrogates cell cycle progression at G1 and S phases. Biochem. Biophys. Res. Commun. 298(1): 178-183. doi: https://doi.org/10.1016/S0006-291X(02)02416-6
- Matsumoto, K., Akao, Y., Ohguchi, K., Ito, T., Tanaka, T., Iinuma, M., Nozawa, Y. (2005). Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorg. Med. Chem. 13(21): 6064-6069. doi: https://doi.org/10.1016/j.bmc.2005.06.065
- Karimian, A., Ahmadi, Y., Yousefi, B. (2016). Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 42: 63-71. doi: https://doi.org/10.1016/j.dnarep.2016.04.008
- Zhu, H., Zhang, L., Wu, S., Teraishi, F., Davis, J.J., Jacob, D., Fang, B. (2004). Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino] ethanol in correlation with activation of ERK. Oncogene. 23(29): 4984-4992. doi: https://doi.org/10.1038/sj.onc.1207645
- Shaw, P.H. (1996). The role of p53 in cell cycle regulation. Pathol. Res. Pract. 192(7): 669-675. doi: https://doi.org/10.1016/S0344-0338(96)80088-4
- Cincin, Z.B., Unlu, M., Kiran, B., Bireller, E.S., Baran, Y., Cakmakoglu, B. (2015). Apoptotic Effects of Quercitrin on DLD-1 Colon Cancer Cell Line. Pathol. Oncol. Res. 21(2): 333-338. doi: https://doi.org/10.1007/s12253-014-9825-3